The spectrum of novel ABCB11 gene variations in children with progressive familial intrahepatic cholestasis type 2 in Pakistani cohorts.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 08 2024
Historique:
received: 28 08 2023
accepted: 17 04 2024
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 14 8 2024
Statut: epublish

Résumé

Progressive familial intrahepatic cholestasis (PFIC) is a rare childhood manifested disease associated with impaired bile secretion with severe pruritus yellow stool, and sometimes hepatosplenomegaly. PFIC is caused by mutations in ATP8B1, ABCB11, ABCB4, TJP2, NR1H4, SLC51A, USP53, KIF12, ZFYVE19, and MYO5B genes depending on its type. ABCB11 mutations lead to PFIC2 that encodes the bile salt export pump (BSEP). Different mutations of ABCB11 have been reported in different population groups but no data available in Pakistani population being a consanguineous one. We sequenced coding exons of the ABCB11 gene along with its flanking regions in 66 unrelated Pakistani children along with parents with PFIC2 phenotype. We identified 20 variations of ABCB11: 12 in homozygous form, one compound heterozygous, and seven heterozygous. These variants include 11 missenses, two frameshifts, two nonsense mutations, and five splicing variants. Seven variants are novel candidate variants and are not detected in any of the 120 chromosomes from normal ethnically matched individuals. Insilico analysis revealed that four homozygous missense variations have high pathogenic scores. Minigene analysis of splicing variants showed exon skipping and the addition of exon. This data is a useful addition to the disease variants genomic database and would be used in the future to build a diagnostic algorithm.

Identifiants

pubmed: 39143102
doi: 10.1038/s41598-024-59945-0
pii: 10.1038/s41598-024-59945-0
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily B, Member 11 0
ABCB11 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18876

Subventions

Organisme : Higher Education Commision, Pakistan
ID : 213-67920-2MB2-106

Informations de copyright

© 2024. The Author(s).

Références

Camilleri, M. & Gores, G. J. Therapeutic targeting of bile acids. Am. J. Physiol. Gastrointest. Liver Physiol. 309(4), G209–G215 (2015).
doi: 10.1152/ajpgi.00121.2015 pubmed: 26138466 pmcid: 4537926
Jansen, P. L. et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 117, 1370–1379 (1999).
doi: 10.1016/S0016-5085(99)70287-8 pubmed: 10579978
Kato, T., Hayashi, H. & Sugiyama, Y. Short-and medium-chain fatty acids enhance the cell surface expression and transport capacity of the bile salt export pump (BSEP/ABCB11). Biochim. Biophys. Acta Mol. Cell 1801(9), 1005–1012 (2010).
doi: 10.1016/j.bbalip.2010.04.002
Hu, G. et al. Diagnosis of ABCB11 gene mutations in children with intrahepatic cholestasis using high resolution melting analysis and direct sequencing. Mol. Med. Rep. 10(3), 1264–1274 (2014).
doi: 10.3892/mmr.2014.2349 pubmed: 24969679 pmcid: 4121405
Jackson, J. P. et al. Basolateral efflux transporters: A potentially important pathway for the prevention of cholestatic hepatotoxicity. Appl. Vitro Toxicol. 2, 207–216 (2016).
doi: 10.1089/aivt.2016.0023
Knisely, A. S. Perspectives in pediatric pathology: Progressive familial intrahepatic cholestasis: A personal perspective. Pediatr. Dev. Pathol. 3, 113–125 (2000).
doi: 10.1007/s100240050016 pubmed: 10679031
Kubitz, R., Dröge, C., Stindt, J., Weissenberger, K. & Häussinger, D. The bile salt export pump (BSEP) in health and disease. Clin. Res. Hepatol. Gastroenterol. 36, 536–553 (2012).
doi: 10.1016/j.clinre.2012.06.006 pubmed: 22795478
Kubitz, R., Keitel, V. & Scheuring, S. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J. Clin. Gastroenterol. 40, 171–175 (2006).
doi: 10.1097/01.mcg.0000196406.15110.60 pubmed: 16394881
Lang, C. et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacol. Genet. 17, 47–60 (2007).
Baker, A. et al. A systematic review of progressive familial intrahepatic cholestasis. Clin. Res. Hepatol. Gastroenterol. 43(1), 20–36 (2019).
doi: 10.1016/j.clinre.2018.07.010 pubmed: 30236549
Strautnieks, S. S. et al. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am. J. Hum. Genet. 61(3), 630–633 (1997).
doi: 10.1086/515501 pubmed: 9326328 pmcid: 1715942
Davit-Spraul, A. et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 5, 1645–1655 (2010).
doi: 10.1002/hep.23539
Hori, T., Nguyen, J. H. & Uemoto, S. Progressive familial intrahepatic cholestasis. Hepatobil. Pancreatic Dis. Int. 9, 570–578 (2010).
Liu, L. Y., Wang, Z. L., Wang, X. H., Zhu, Q. R. & Wang, J. S. ABCB11 gene mutations in Chinese children with progressive intrahepatic cholestasis and low γ glutamyltransferase. Liver Int. 30, 809–815 (2016).
doi: 10.1111/j.1478-3231.2009.02112.x
Misawa, T., Hayashi, H., Makishima, M., Sugiyama, Y. & Hashimoto, Y. E297G mutated bile salt export pump (BSEP) function enhancers derived from GW4064: Structural development study and separation from farnesoid X receptor-agonistic activity. Bioorg. Med. Chem. Lett 15, 3962–3966 (2012).
doi: 10.1016/j.bmcl.2012.04.099
Byrne, J. A. et al. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 49, 553–567 (2009).
doi: 10.1002/hep.22683 pubmed: 19101985
Strautnieks, S. S. et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 134, 1203–1214 (2008).
doi: 10.1053/j.gastro.2008.01.038 pubmed: 18395098
Bull, L. N. et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat. Genet. 18, 219–224 (1998).
doi: 10.1038/ng0398-219 pubmed: 9500542
Chen, H. L. et al. Diagnosis of BSEP/ABCB11 mutations in Asian patients with cholestasis using denaturing high performance liquid chromatography. J. Pediatr. 153, 825–832 (2008).
doi: 10.1016/j.jpeds.2008.06.034 pubmed: 18692205
Li-Yan, L., Zhong, L. W., Xiao, H. W. & Qi-Rong, Z. ABCB11 gene mutations in Chinese children with progressive intrahepatic cholestasis and low γ glutamyltransferase. Liver Int. 30(6), 809–815 (2009).
doi: 10.1111/j.1478-3231.2009.02112.x
Ng, P. C. & Henikoff, S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812–3814 (2003).
doi: 10.1093/nar/gkg509 pubmed: 12824425 pmcid: 168916
Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 76, 7–20 (2013).
Goto, K. et al. Bile salt export pump gene mutations in two Japanese patients with progressive familial intrahepatic cholestasis. J. Pediatr. Gastroenterol. Nutr. 36(5), 647–650 (2003).
pubmed: 12717091
Strautnieks, S. S. et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 134(4), 1203–1214 (2008).
doi: 10.1053/j.gastro.2008.01.038 pubmed: 18395098
Dröge, C. et al. Sequencing of FIC1, BSEP, and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants. J. Hepatol. 67(6), 1253–1264 (2017).
doi: 10.1016/j.jhep.2017.07.004 pubmed: 28733223
Byrne, J. A. et al. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 49(2), 553–567 (2009).
doi: 10.1002/hep.22683 pubmed: 19101985
Evason, K. et al. Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): Correlation with genetic and immunohistochemical studies. Am. J. Surg. Pathol. 35(5), 687–696 (2011).
doi: 10.1097/PAS.0b013e318212ec87 pubmed: 21490445 pmcid: 3416050
Shah, I. & Chilkar, S. Progressive familial intrahepatic cholestasis type 2 in an Indian child. Case reports. J. Pediatr. Genet. 6(2), 126–127 (2017).
doi: 10.1055/s-0036-1597912 pubmed: 28497004 pmcid: 5423798
Alvarez, L. et al. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated with a mutation in ATP8B1. Hum. Mol. Genet. 13(20), 2451–2460 (2004).
doi: 10.1093/hmg/ddh261 pubmed: 15317749
Afzal, M., Ali, S. M., Siyal, H. B. & Hakim, A. Consanguineous marriages in Pakistan. Pak. Dev. Rev. 33, 663–676 (1994).
doi: 10.30541/v33i4IIpp.663-676 pubmed: 12346199
Zahoor, Y. M., Cheema, H. A., Ijaz, S. & Fayyaz, Z. Genetic analysis of tyrosinemia type 1 and fructose-1, 6 bisphosphatase deficiency affected in Pakistani cohorts. Fetal Pediatr. Pathol. 39, 430–440 (2020).
doi: 10.1080/15513815.2019.1672224
Evason, K. et al. Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): Correlation with genetic and immunohistochemical studies. Am. J. Surg. Pathol. 35, 687 (2011).
doi: 10.1097/PAS.0b013e318212ec87 pubmed: 21490445 pmcid: 3416050
Leabman, M. K. et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc. Natl. Acad. Sci. 10, 5896–5901 (2003).
doi: 10.1073/pnas.0730857100
Wang, L. et al. Cryo-EM structure of human bile salts exporter ABCB11. Cell Res. 30, 623–625 (2020).
doi: 10.1038/s41422-020-0302-0 pubmed: 32203132 pmcid: 7343855

Auteurs

Hafsa Riaz (H)

Department of Pediatrics, University of Alberta, Edmonton, Canada.
Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore, Pakistan.

Bixia Zheng (B)

Department of Gastroenterology, Children's Hospital of Nanjing Medical University, Nanjing, People's Republic of China.

Yucan Zheng (Y)

Department of Gastroenterology, Children's Hospital of Nanjing Medical University, Nanjing, People's Republic of China.

Zhifeng Liu (Z)

Department of Gastroenterology, Children's Hospital of Nanjing Medical University, Nanjing, People's Republic of China.

Hong-Mei Gu (HM)

Department of Pediatrics, University of Alberta, Edmonton, Canada.

Muhammad Imran (M)

Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore, Pakistan.

Tahir Yaqoob (T)

Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan.

Munir Ahmad Bhinder (MA)

Department of Human Genetics and Molecular Biology, University of Health Sciences, Lahore, Pakistan.

Da-Wei Zhang (DW)

Department of Pediatrics, University of Alberta, Edmonton, Canada. dzhang@ualberta.ca.

Muhammad Yasir Zahoor (MY)

Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore, Pakistan. yasir.zahoor@uvas.edu.pk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH